by Protea Foundation | Apr 15, 2024 | News
35th Annual Boston International Trauma Conference Protea Foundation is joining Bessel van der Kolk and the Trauma Research Foundation from May 1st to 4th for the 35th Annual Boston International Trauma Conference. The Trauma Research Foundation has a legacy spanning...
by Protea Foundation | Mar 16, 2024 | News
Psychedelics are outperforming trauma researchers’ expectations. But why? A new study offers big clues about where psychedelics’ superpowers come from. By Sigal Samuel Jan 29, 2024, 7:00am EST Bessel van der Kolk, one of the world’s top trauma experts, was...
by Protea Foundation | Mar 14, 2024 | News
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial Results from the phase 3 placebo-controlled MAPP2 trial show that MDMA-assisted therapy reduces post-traumatic stress disorder (PTSD) symptoms and functional impairment...
by Protea Foundation | Mar 14, 2024 | News
Devastatingly pervasive: 1 in 3 women globally experience violence Younger women among those most at risk: WHO Violence against women remains devastatingly pervasive and starts alarmingly young, shows new data from WHO and partners. Across their lifetime, 1 in...
by Protea Foundation | Mar 13, 2024 | News
Psychedelic Drug Legislative Reform and Legalization in the US Psychedelic drugs are becoming accessible in the US through a patchwork of state legislative reforms. This shift necessitates consensus on treatment models, education and guidance for health care...
